BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 236 filers reported holding BEAM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,708,500 | -24.7% | 570,000 | 0.0% | 1.52% | -4.7% |
| Q2 2023 | $18,200,100 | +4.3% | 570,000 | 0.0% | 1.59% | +10.6% |
| Q1 2023 | $17,453,400 | +20.6% | 570,000 | +54.1% | 1.44% | +28.3% |
| Q4 2022 | $14,470,700 | -17.9% | 370,000 | 0.0% | 1.12% | -3.2% |
| Q3 2022 | $17,627,000 | +21.4% | 370,000 | -1.3% | 1.16% | -5.6% |
| Q2 2022 | $14,516,000 | -69.1% | 375,000 | -54.2% | 1.23% | -41.7% |
| Q1 2022 | $46,918,000 | -28.1% | 818,820 | 0.0% | 2.10% | +14.4% |
| Q4 2021 | $65,252,000 | -8.4% | 818,820 | 0.0% | 1.84% | +3.7% |
| Q3 2021 | $71,246,000 | -32.4% | 818,820 | 0.0% | 1.77% | -33.7% |
| Q2 2021 | $105,390,000 | +60.8% | 818,820 | 0.0% | 2.68% | +37.0% |
| Q1 2021 | $65,538,000 | +74.5% | 818,820 | +78.0% | 1.95% | +75.4% |
| Q4 2020 | $37,554,000 | – | 460,000 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |